Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 341 of 5804
-
New combo therapy aims to shrink prostate cancer tumors
Disease control Recruiting nowThe purpose of the study is to evaluate the safety, tolerability, and efficacy of the two different treatment combinations of tulmimetostat in participants with de novo or recurrent Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New cholera vaccine trial aims to protect families in High-Risk areas
⭐️ VACCINE ⭐️ Recruiting nowThis phase II study is intended to determine the immunogenicity and safety of single dose and two doses of OSP:rTTHc cholera conjugate vaccine (CCV) with or without alum adjuvant. The study will guide the future dosing schedule and formulation of CCV (with or without Aluminum pho…
Phase: PHASE2 • Sponsor: International Vaccine Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:03 UTC
-
New Shot-in-Tumor combo aims to beat melanoma before surgery
Disease control Recruiting nowThe success of anti-PD-1 and anti-CTLA-4 therapies has initiated a paradigm shift in oncology, with drugs now targeting the immune system rather than cancer cells to stimulate the antitumor immune response. Intratumoral (IT) delivery of immunostimulating agents reduces the system…
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Video games as therapy: VR may boost balance in teens with cerebral palsy
Disease control Recruiting nowThis randomized controlled trial aims to compare the effectiveness of fully immersive Mixed Reality (MR) combined with standard physical therapy versus standard physical therapy alone in improving balance and coordination among adolescents with spastic diplegic cerebral palsy. A …
Phase: NA • Sponsor: Ibadat International University, Islamabad • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New combo therapy hopes to tackle childhood brain tumors
Disease control Recruiting nowThis is a 3-part open-label study (feasibility phase, treatment phase and follow-up phase) of orally administered mirdametinib in combination with intravenous vinblastine chemotherapy in patients with PLGG with activation of MAPK pathway. Feasibility Phase: The maximum tolerate…
Phase: PHASE1, PHASE2 • Sponsor: St. Justine's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Smartphone heart check: could your phone save your life?
Diagnosis Recruiting nowHeart valve diseases are among the most serious cardiovascular conditions in older age. One of the most common forms is aortic valve stenosis, a narrowing of the valve opening between the left ventricle and the main artery. As the valve becomes tighter, the heart must work harder…
Sponsor: Medical University Innsbruck • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
New pill could tame tough psoriasis without injections
Disease control Recruiting nowThis study is a randomized, double-blind, placebo- and active-controlled multicenter clinical trial involving patients with moderate to severe plaque psoriasis. Safety and efficacy assessments will be conducted during the scheduled study visits throughout the trial. After comple…
Phase: PHASE3 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Low-Dose radiation plus immunotherapy shows promise for Tough-to-Treat nasopharyngeal cancer
Disease control Recruiting nowThis study aims to evaluate the efficacy and safety of LDRT combined with toripalimab and GP chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma through a prospective, open-label, single-arm Phase II clinical trial.
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Lung valves could starve Drug-Resistant TB cavities
Disease control Not yet recruitingTuberculosis (TB) is a complex disease in which the lungs are the primary site of infection. Infection is acquired through inhalation of droplet nuclei laden with Mycobacterium bacilli (M. tuberculosis) that settle in the alveoli as the primary focus. TB is characterized by a gra…
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria Careggi • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New stroke drug combo aims to boost recovery in major trial
Disease control Not yet recruitingThe investigators propose to assess the efficacy and safety of intravenous tirofiban after bridging therapy (endovascular therapy \[EVT\] following intravenous Tenecteplase) for acute ischemic stroke due to intracranial atherosclerotic disease related large vessel occlusion (ICAD…
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo shot study: could VAX-31 plus flu vaccine be a Game-Changer for seniors?
Prevention OngoingThis is a Phase 3, randomized, double-blind study to evaluate the safety and immunogenicity of VAX-31 and seasonal influenza vaccine in pneumococcal-naïve adults ≥ 50 years when the two vaccines are administered at the same visit or separately.
Phase: PHASE3 • Sponsor: Vaxcyte, Inc. • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
New device aims to stop deadly postpartum bleeding when drugs fail
Disease control Recruiting nowabnormal bleeding after childbirth. This condition is called abnormal bleeding and becomes a condition known as postpartum hemorrhage (PPH) when worsens. Abnormal bleeding is defined as the loss of more than 500 milliliters (about two cups) of blood after a vaginal birth, or more…
Phase: PHASE3 • Sponsor: ResQ Medical Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Diabetes remission possible without drugs? new trial investigates lifestyle overhaul
Disease control Not yet recruitingThe purpose of this clinical trial is to determine whether an intensive lifestyle intervention can achieve remission of type 2 diabetes mellitus (T2DM) in adult patients treated in primary care. The main questions the study seeks to answer are: * What proportion of participants …
Phase: NA • Sponsor: Parc Sanitari Pere Virgili • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Pap smear upgrade? DNA test could spot hidden uterine cancer
Diagnosis Not yet recruitingThe goal of this observational study is to evaluate the accuracy of a novel molecular test for screening and monitoring endometrial lesions in women at medium-to-high risk for endometrial cancer. The main questions it aims to answer are: * What is the sensitivity and specificit…
Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Breathing without a tube: new strategy aims to speed lung transplant recovery
Disease control Not yet recruitingThe goal of this study is to learn whether a spontaneous-breathing ("tubeless") anesthesia and surgery strategy can improve early recovery and remain safe for adults who receive a lung transplant. This strategy aims to help lung transplant recipients maintain spontaneous breathin…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Promising cocktail aims to save voice boxes in head and neck cancer
Disease control Not yet recruitingAlthough multiple immune-checkpoint inhibitors (ICIs) have demonstrated efficacy in recurrent or metastatic squamous-cell carcinoma of the head and neck (R/M-SCCHN), outcomes in the locally advanced (LA-SCCHN) setting remain suboptimal, and treatment continues to pose a major the…
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New combo therapy aims to shrink lung tumors before surgery
Disease control Recruiting nowThis study aims to evaluate the major pathologic response (MPR) rate of neoadjuvant therapy with sintilimab (PD-1 inhibitor) + IBI310 (anti-CTLA-4 antibody) + chemotherapy, and to assess the efficacy of this treatment strategy in patients with PD-L1-negative stage II - IIIB (excl…
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
High-Tech gait training shows promise for spinal cord injury recovery
Symptom relief Recruiting nowThe goal of this clinical trial is to determine whether combining Functional Electrical Stimulation (FES) with Augmented Reality (AR)-based gait training can improve walking ability in individuals with incomplete spinal cord injury (SCI). The study aims to identify the most effec…
Phase: NA • Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Blood test catches cancer early; drug aims to stop return
Disease control Not yet recruitingThe goal of this clinical study is to determine whether monitoring ctDNA and treating patients who become ctDNA-positive with abemaciclib can help prevent the recurrence of hormone receptor-positive, HER2-negative breast cancer after curative surgery and standard therapy. The stu…
Phase: PHASE2 • Sponsor: Nagoya City University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New mRNA shingles vaccine enters phase 2 trial – could it be a game changer?
⭐️ VACCINE ⭐️ Not yet recruitingHerpes zoster is caused by the reactivation of latent varicella-zoster virus (VZV) which stays in latency after its primary infection. Immunosenescence contributes significantly to elevating morbidity associated with aging. Vaccination plays a key role in reducing the disease bur…
Phase: PHASE2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:12 UTC